REMINYL

This brand name is authorized in Austria, Australia, Brazil, Ecuador, Spain, Finland, France, Hong Kong, Ireland, Israel, Italy, Japan, Malta, Mexico, Netherlands, New Zealand, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug REMINYL contains one active pharmaceutical ingredient (API):

1 Galantamine UNII MJ4PTD2VVW - GALANTAMINE HYDROBROMIDE

Galantamine, a tertiary alkaloid is a selective, competitive and reversible inhibitor of acetylcholinesterase. In addition, galantamine enhances the intrinsic action of acetylcholine on nicotinic receptors, probably through binding to an allosteric site of the receptor. As a consequence, an increased activity in the cholinergic system associated with improved cognitive function can be achieved in patients with dementia of the Alzheimer type. Read about Galantamine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06DA04	Galantamine	N Nervous system → N06 Psychoanaleptics → N06D Anti-dementia drugs → N06DA Anticholinesterases
Discover more medicines within N06DA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11899G, 11917F, 11918G, 2463P, 2531F, 2537M, 8770N, 8771P, 8772Q
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 514506001115311, 514506002111311, 514506003118318
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 26.557-08-05, 26.561-08-05
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 63388, 66650, 66651, 66652, BE269473
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 002018, 017762, 017763, 017773, 017787, 017809
Country: FR	Base de données publique des médicaments	Identifier(s): 61601453
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 146216, 146220, 146222, 175909, 186097, 34450, 368235, 368237, 373961, 93027, 93031, 93034
Country: HK	Department of Health Drug Office	Identifier(s): 55292, 55293, 55294
Country: IE	Health Products Regulatory Authority	Identifier(s): 36100, 36101, 36102, 43937, 44203, 44229, 44258, 44266, 51208, 51387
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6006, 6007, 6008
Country: IT	Agenzia del Farmaco	Identifier(s): 034752117, 034752131, 034752170
Country: JP	医薬品医療機器総合機構	Identifier(s): 1190019F1028, 1190019F2024, 1190019F3020, 1190019F4027, 1190019F5023, 1190019F6020, 1190019S1026
Country: MT	Medicines Authority	Identifier(s): MA018/00104
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 144M2004, 211M2001
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 76767, 76775, 76783
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11188, 11189, 11190
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W41503001
Country: SG	Health Sciences Authority	Identifier(s): 13019P, 13020P, 13021P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699593151163, 8699593595233
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/5.3/0202, 34/5.3/0203, 34/5.3/0204, 34/5.3/0206, 38/5.3/0311, 38/5.3/0312, 38/5.3/0313